Login

I cannot remember my username

Ray Blanco’s FDA Trader

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

It is designed to alert you to breakout moves could ultimately drive huge stock market gains...

Flash Sell! Weak Data Means it’s Time To Close This Trade

By Ray BlancoPosted August 8, 2018

The latest report for one gene therapy company was disappointing, unfortunately it’s time to close out. Plus, information on an antibiotics play and a successful advisory meeting…

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Ray Blanco’s FDA Trader

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

LoginGet Access

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits and Technology Profits Daily. Ray has been with Seven Figure Publishing for nine years. In 2018, his closed positions in Technology Profits Confidential averaged over 100% gains.

View More By Ray Blanco

Related Posts

IMPORTANT: FDA Gives Approval to Durata Therapeutics for Its Incredible New Antibiotic

By Josh GrasmickPosted May 23, 2014

We've just received word that the Food and Drug Administration (FDA) has approved our PDUFA Booster Shot’s antibiotic drug for use in the United States. The stock is halted right now, meaning no one can buy or sell shares. Because of the Memorial Day holiday, the next chance to transact in Durata Therapeutics stock will be Tuesday, May 27. Paul is monitoring the situation and will send you an alert on what you should do with your Durata Therapeutics stock on Tuesday.

Some Great Trades in Our Portfolio You Shouldn’t Miss

By Ray BlancoPosted November 4, 2015

There's nothing in the market like biotech for earning big profits fast . We've seen triple-digit runs in some of our picks in a matter of days, and double-digit rocket ships in just a single trading session. It all turns on two things: science and news.